Solventum Announces Agreement to Acquire Acera Surgical
— Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million market segment in the U.S. — Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacency Solventum(NYSE: SOLV) announced today it […]